Cook S, et al. Updated safety analysis of cladribine tablets in the treatment of patients with multiple sclerosis. ECTRIMS 2018, P875.
Langetermijnresultaten bevestigen fase III-data van cladribine (ECTRIMS 2019 in Stockholm)
okt 2019 | Multipele Sclerose